Aravive Inc. (ARAV) Fundamentals

Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. Aravive's lead candidate is batiraxcept, which is is an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway.
SHARE INFORMATION
Market Cap$ 28,238,554
Shares Outstanding30,518,269
Float19,492,717
Percent Float63.87%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 7,442,000
Latest Fiscal EPS$ -1.94
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions114
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months80,265
Institutional Holdings Percent21.5%
Institutional Sold Previous 3 Months1,423,931
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months490,000
Insider Holdings Percent13.3
Insider Sold Previous 3 Months-
Insider Shares Owned3,819,800
TRADING INFO
52 Week High$ 4.40
52 Week Low$ 0.80
52 Week High Change$ -77.49
21 Day Moving Average$ 0.8928
21 Day Extended Moving Average$ 0.918465
50 Day Moving Average$ 0.9816
50 Day Extended Moving Average$ 1.0106
200 Day Moving Average$ 1.9593
200 Day Extended Moving Average$ 1.9941
10 Day Average Volume109,227
20 Day Average Volume88,628
30 Day Average Volume87,321
50 Day Average Volume106,339
Alpha-0.053964
Beta2.3916
Standard Deviation0.291868
R20.167961
7 Day Price Change$ 0.0153
7 Day Percent Change1.68%
21 Day Price Change$ -0.0047
21 Day Percent Change-0.51%
30 Day Price Change$ -0.0435
30 Day Percent Change-4.49%
Month to Date Price Change$ 0.0523
Month to Date Percent Change5.99%
Quarter to Date Price Change$ -0.0626
Quarter to Date Percent Change-6.34%
180 Day Price Change$ -1.14
180 Day Percent Change-55.3%
200 Day Price Change$ -1.30
200 Day Percent Change-58.51%
Year to Date Price Change$ -1.26
Year to Date Percent Change-57.75%

Aravive Inc. (ARAV) Key Ratios

PROFITABILITY
EBIT Margin-575.5%
EBITDA Margin-563.9%
Pre-Tax Profit Margin-1,603.3%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 4,489,000
Revenue Per Share$ 0.1471
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.80
Total Debt To Equity0.20
Int Coverage0.00
Current Ratio3.50
Leverage Ratio1.70
Quick Ratio3.30
Long Term Debt To Capital0.08
VALUATION MEASURES
PE Ratio-0.50
Enterprise Value$ -30,130,097
Price to Sales6.2906
Price to Free Cash-1.00
PE High Last 5 Years-1.10
Price To Book0.80
Price To Cash Flow0.00
PE Low Last 5 Years-2.10
Price to Tangible Book0.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover38.40
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-56.57
Return on Equity-84.94
Return on Capital-72.56

Aravive Inc. (ARAV) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorBDO USA, LLP
CEOGail McIntyre
Emplyoees23
Last AuditUE
CIK0001513818
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address3730 Kirby Drive
River Oaks Tower, Suite 1200
Houston, TX 77098
Websitehttps://www.aravive.com
Facsimile-
Telephone+1 936 355-1910
Emailmzanoni@enduranceadvisors.com


Your Recent History
NASDAQ
ARAV
Aravive
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.